InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,287.60
(
-0.24%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,937.37
(
-0.69%
)
Post# of 253171
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 61
Posts 11570
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: DewDiligence post# 189363

Monday, 03/30/2015 12:04:48 PM

Monday, March 30, 2015 12:04:48 PM

Post# of 253171

ABBV had a similar problem with Humira, but that’s well on its way to being rectified




You really think Abbv has the loss of Humeria sales covered? Everyone likes to claim that Copaxone represents a 50% portion of Teva's profits but isn't Humeria responsible for close to 65% of Abbvie's profits?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up